BOM P3 never/ever? Gosh if B OM is so good then where is that big deal? Lemme check, lemme re read: oh yeah, B OM: one subgroup with tiny numbers showed a benefit, but overall data not good.
Good trial data woulda brought a very big deal a very long long time ago
P3 limps forward maybe- that is all. Therefore, no deal yet, and maybe never